Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 12, 2009, Pages 1526-1535

  Naehle, Claas P ^a   Zeijlemaker, Volkert ^b   Thomas, Daniel ^a   Meyer, Carsten ^a   Strach, Katharina ^a   Fimmers, Rolf ^a   Schild, Hans ^a   Sommer, Torsten ^c  

^a UNIVERSITY OF BONN   (Germany)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^c German Red Cross Hospital   (Germany)

Author keywords

1.5T; Cumulative effects; MRI; Pacemaker; Safety

Indexed keywords

CLINICAL EVALUATION; ELECTRIC POTENTIAL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART VENTRICLE PACING; HUMAN; INFORMED CONSENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PATIENT SAFETY; POTENTIOMETRY; REPEAT PROCEDURE; REVIEW; RISK ASSESSMENT; SINUS NODE;

EQUIPMENT DESIGN; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL;

EID: 70449724740     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02570.x     Document Type: Review

References (30)

1. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, et al. MR imaging and cardiac pacemakers: In vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology 2000 215 : 869 879.
2. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: In vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004 110 : 475 482.
3. Schmiedel A, Hackenbroch M, Yang A, Nahle CP, Skowasch D, Meyer C, Schimpf R, et al. Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla. Rofo 2005 177 : 731 744.
4. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation 2006 114 : 1277 2784.
5. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients. A prospective study with 115 examinations. Circulation 2006 114 : 1285 1292.
6. Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, Luechinger R, et al. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: Pilot prospective study with 51 examinations. Radiology 2008 249 : 991 1001.
7. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: An American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007 116 : 2878 2891.
8. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, Auricchio A, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008 10 : 336 346. (Pubitemid 351773738)
9. Faris OP, Shein M. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006 114 : 1232 1233.
10. Faris OP, Shein MJ. Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005 28 : 268 269.
11. Armour EP, McEachern D, Wang Z, Corry PM, Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res 1993 53 : 2740 2744.
12. Martinez AA, Meshorer A, Meyer JL, Hahn GM, Fajardo LF, Prionas SD. Thermal sensitivity and thermotolerance in normal porcine tissues. Cancer Res 1983 43 : 2072 2075.
13. Irnich W. Threshold measurements: Ten rules for good measuring practice. Pacing Clin Electrophysiol 2003 26 : 1738 1746.
14. Preston TA, Fletcher RD, Lucchesi BR, Judge RD. Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. Am Heart J 1967 74 : 235 242.
15. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Luderitz B. Interference with cardiac pacemakers by magnetic resonance imaging: Are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol 2001 24 : 489 495.
16. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997 134 : 467 473.
17. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005 26 : 376 383 discussion 325-377. (Pubitemid 40283097)
18. Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999 99 : 262 270.
19. Wittkampf FH, Hauer RN, Robles de Medina EO. Control of radiofrequency lesion size by power regulation. Circulation 1989 80 : 962 968.
20. Luechinger R. Safety aspects of cardiac pacemakers in magentic resonance imaging. Swiss Federal Institute of Technology Zurich. Zuerich, ETH Zuerich, 2002, pp. 131.
21. Luechinger R, Duru F, Zeijlemaker V, Scheidegger MB, Candinas R, Boesiger P. Heating efffects of MRI on pacemaker leads: Send/receive coil versus receive-only coils. 50th Annual Scientific Session of the American College of Cardiology. Orlando, Florida, 2001.
22. Luechinger R, Duru F, Scheidegger MB, Candinas R, Boesiger P. Heating effects of magnetic resonance imaging on pacemaker leads: Effect of lead types and positioning. Proc Intl Soc Mag Reson Med 1999 7:103.
23. Luechinger R, Zeijlemaker V, Duru F, Boesiger P. RF-heating effects on coated wires and pacemaker leads at 1.5T and 3.0T. Proc Intl Soc Mag Reson Med 2006 14:2036.
24. Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F, Herold V, et al. Measuring RF-induced currents inside implants: Impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med 2009 61 : 570 578.
25. Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: Are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002 25 : 1419 1423.
26. Scheibelhofer W, Glogar D, Probst P, Milczoch J, Kaindl F. Induction of ventricular tachycardia by pacemaker programming. Pacing Clin Electrophysiol 1982 5 : 587 592.
27. Gimbel JR. Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. Europace 2009 11 : 1241 1242.
28. Tandri H, Zviman MM, Wedan SR, Lloyd T, Berger RD, Halperin H. Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm 2008 5 : 462 468.
29. Nowak B. Is asynchronous ventricular pacemaker stimulation dangerous? Results of an international survey. Dtsch Med Wochenschr 2005 130 : 997 1001.
30. Nowak B, Hemmer W, Israel CW, Kramer LI, Neuzner J, Pfeiffer D, Rybak K, et al. Statement of the Working Group of the Germany Society on the safety of asynchronous ventricular pacemaker stimulation. Clin Res Cardiol 2006 95 : 57 60.